Defining the role of polyamines in colon carcinogenesis using mouse models

Journal of Carcinogenesis

Volumn 10, Issue , 2011, Pages

  Ignatenko, Natalia ^a   Gerner, Eugene ^a   Besselsen, David ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Apc Min +; DFMO; mouse models; NSAIDs; polyamines; SLC3A2

Indexed keywords

ACYLTRANSFERASE; ADENOSYLMETHIONINE DECARBOXYLASE; ANTIZYME; ARGININE; CELECOXIB; CITRULLINE; EFLORNITHINE; K RAS PROTEIN; N1 ACETYLSPERMIDINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE DECARBOXYLASE; OXIDOREDUCTASE; POLYAMINE; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53; PUTRESCINE; SPERMIDINE; SPERMIDINE SYNTHASE; SPERMINE; SPERMINE SYNTHASE; SULINDAC; TRANSFORMING GROWTH FACTOR BETA;

ADENOMATOUS POLYP; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RISK; CARCINOGENICITY; CATABOLISM; CHEMICAL STRUCTURE; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; DIET SUPPLEMENTATION; DISEASE COURSE; DRUG POTENTIATION; ENZYME ACTIVITY; GENE INACTIVATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC ENGINEERING; GENETIC RISK; IN VIVO STUDY; KNOCKOUT MOUSE; NONHUMAN; POLYAMINE METABOLISM; POLYAMINE SYNTHESIS; PROMOTER REGION; RELIABILITY; REPRODUCIBILITY; REVIEW; RISK FACTOR;

EID: 84860255903     PISSN: 09746773     EISSN: 14773163     Source Type: Journal    
DOI: 10.4103/1477-3163.79673     Document Type: Review

References (72)

1. Igarashi K, Kashiwagi K. Polyamines: mysterious modulators of cellular functions. Biochem Biophys Res Commun 2000;271:559-64. (Pubitemid 30444667)
2. Matsufuji S, Matsufuji T, Miyazaki Y, Murakami Y, Atkins JF, Gesteland RF, et al. Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme. Cell 1995;80:51-60.
3. Pegg AE. Mammalian polyamine metabolism and function. IUBMB Life 2009;61:880-94.
4. Schipper RG, Penning LC, Verhofstad AA. Involvement of polyamines in apoptosis. Facts and controversies: effectors or protectors? Semin Cancer Biol 2000;10:55-68. (Pubitemid 30391957)
5. Thomas T, Thomas TJ. Polyamine metabolism and cancer. J Cell Mol Med 2003;7:113-26. (Pubitemid 37123597)
6. Gerner EW, Meyskens FL Jr. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 2004;4:781-92. (Pubitemid 39331150)
7. Persson L. Polyamine homoeostasis. Essays Biochem 2009;46:11-24.
8. Meyskens FL Jr, Gerner EW. Development of difluoromethylornithine as a chemoprevention agent. Clin Cancer Res 1999;5:945-51.
9. Meyskens FL Jr, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, et al. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila) 2008;1:32-8.
10. Pendeville H, Carpino N, Marine JC, Takahashi Y, Muller M, Martial JA, et al. The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol Cell Biol 2001;21:6549-58. (Pubitemid 32927422)
11. Kauppinen RA, Alhonen LI. Transgenic animals as models in the study of the neurobiological role of polyamines. Prog Neurobiol 1995;47:545-63. (Pubitemid 26040246)
12. Pegg AE. Regulation of ornithine decarboxylase. J Biol Chem 2006;281:14529.
13. Nilsson JA, Maclean KH, Keller UB, Pendeville H, Baudino TA, Cleveland JL. Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation. Mol Cell Biol 2004;24:1560-9. (Pubitemid 38167078)
14. Coffino P. Regulation of cellular polyamines by antizyme. Nat Rev Mol Cell Biol 2001;2:188-94. (Pubitemid 33675743)
15. Heller JS, Fong WF, Canellakis ES. Induction of a protein inhibitor to ornithine decarboxylase by the end products of its reaction. Proc Natl Acad Sci USA 1976;73:1858-62.
16. Hoshino K, Momiyama E, Yoshida K, Nishimura K, Sakai S, Toida T, et al. Polyamine transport by mammalian cells and mitochondria: role of antizyme and glycosaminoglycans. J Biol Chem 2005;280:42801-8. (Pubitemid 43050934)
17. Mitchell JL, Judd GG, Bareyal-Leyser A, Ling SY. Feedback repression of polyamine transport is mediated by antizyme in mammalian tissue-culture cells. Biochem J 1994;299:19-22. (Pubitemid 24106282)
18. Feith DJ, Shantz LM, Pegg AE. Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis. Cancer Res 2001;61:6073-81. (Pubitemid 32762542)
19. Hayashi S, Murakami Y, Matsufuji S. Ornithine decarboxylase antizyme: a novel type of regulatory protein. Trends Biochem Sci 1996;21:27-30. (Pubitemid 26032305)
20. Wan T, Hu Y, Zhang W, Huang A, Yamamura K, Tang H. Changes in liver gene expression of Azin1 knock-out mice. Z Naturforsch C 2010;65:519-27.
21. Pegg AE, Xiong H, Feith DJ, Shantz LM. S-adenosylmethionine decarboxylase: structure, function and regulation by polyamines. Biochem Soc Trans 1998;26:580-6. (Pubitemid 29008128)
22. Kahana C. Ubiquitin dependent and independent protein degradation in the regulation of cellular polyamines. Amino Acids 2007;33:225-30. (Pubitemid 47222965)
23. Yerlikaya A, Stanley BA. S-adenosylmethionine decarboxylase degradation by the 26 S proteasome is accelerated by substrate-mediated transamination. J Biol Chem 2004;279:12469-78. (Pubitemid 38445816)
24. Nishimura K, Nakatsu F, Kashiwagi K, Ohno H, Saito T, Igarashi K. Essential role of S-adenosylmethionine decarboxylase in mouse embryonic development. Genes Cells 2002;7:41-7. (Pubitemid 34121304)
25. Heljasvaara R, Veress I, Halmekyt M, Alhonen L, Jnne J, Laajala P, et al. Transgenic mice overexpressing ornithine and S-adenosylmethionine decarboxylases maintain a physiological polyamine homoeostasis in their tissues. Biochem J 1997;323:457-62. (Pubitemid 27183130)
26. Forshell TP, Rimpi S, Nilsson JA. Chemoprevention of B-cell lymphomas by inhibition of the Myc target spermidine synthase. Cancer Prev Res (Phila) 2010;3:140-7.
27. Meyer RA Jr, Henley CM, Meyer MH, Morgan PL, McDonald AG, Mills C, et al. Partial deletion of both the spermine synthase gene and the Pex gene in the X-linked hypophosphatemic, gyro (Gy) mouse. Genomics 1998;48:289-95. (Pubitemid 28180728)
28. Ikeguchi Y, Wang X, McCloskey DE, Coleman CS, Nelson P, Hu G, et al. Characterization of transgenic mice with widespread overexpression of spermine synthase. Biochem J 2004;381:701-7. (Pubitemid 39120479)
29. Wang X, Levic S, Gratton MA, Doyle KJ, Yamoah EN, Pegg AE. Spermine synthase deficiency leads to deafness and a profound sensitivity to alpha-difluoromethylornithine. J Biol Chem 2009;284:930-7.
30. Pegg AE. Spermidine/spermine-N(1)-acetyltransferase: a key metabolic regulator. Am J Physiol Endocrinol Metab 2008;294:E995-1010.
31. Golab F, Kadkhodaee M, Zahmatkesh M, Hedayati M, Arab H, Schuster R, et al. Ischemic and non-ischemic acute kidney injury cause hepatic damage. Kidney Int 2009;75:783-92.
32. Wang Y, Casero RA Jr. Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both? J Biochem 2006;139:17-25. (Pubitemid 43258842)
33. Zahedi K, Lentsch AB, Okaya T, Barone S, Sakai N, Witte DP, et al. Spermidine/spermine-N1-acetyltransferase ablation protects against liver and kidney ischemia-reperfusion injury in mice. Am J Physiol Gastrointest Liver Physiol 2009;296:G899-909.
34. Wang Y, Devereux W, Stewart TM, Casero RA Jr. Cloning and characterization of human polyamine-modulated factor-1, a transcriptional cofactor that regulates the transcription of the spermidine/spermine N(1)-acetyltransferase gene. J Biol Chem 1999;274:22095-101.
35. Casero RA, Pegg AE. Polyamine catabolism and disease. Biochem J 2009;421:323-38.
36. Niiranen K, Pietil M, Pirttil TJ, Jrvinen A, Halmekyt M, Korhonen VP, et al. Targeted disruption of spermidine/spermine N1-acetyltransferase gene in mouse embryonic stem cells. Effects on polyamine homeostasis and sensitivity to polyamine analogues. J Biol Chem 2002;277:25323-8. (Pubitemid 34951842)
37. Tucker JM, Murphy JT, Kisiel N, Diegelman P, Barbour KW, Davis C, et al. Potent modulation of intestinal tumorigenesis in Apcmin/, mice by the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase. Cancer Res 2005;65:5390-8. (Pubitemid 40827352)
38. Alhonen L, Heikkinen S, Sinervirta R, Halmekyt M, Alakuijala P, Jnne J. Transgenic mice expressing the human ornithine decarboxylase gene under the control of mouse metallothionein I promoter. Biochem J 1996;314:405-8. (Pubitemid 26074749)
39. Pietil M, Alhonen L, Halmekyt M, Kanter P, Jnne J, Porter CW. Activation of polyamine catabolism profoundly alters tissue polyamine pools and affects hair growth and female fertility in transgenic mice overexpressing spermidine/spermine N1-acetyltransferase. J Biol Chem 1997;272:18746-51. (Pubitemid 27318220)
40. Kee K, Foster BA, Merali S, Kramer DL, Hensen ML, Diegelman P, et al. Activated polyamine catabolism depletes acetyl-CoA pools and suppresses prostate tumor growth in TRAMP mice. J Biol Chem 2004;279:40076-83. (Pubitemid 39258282)
41. Min SH, Simmen RC, Alhonen L, Halmekyto M, Porter CW, Janne J, et al. Altered levels of growth-related and novel gene transcripts in reproductive and other tissues of female mice overexpressing spermidine/spermine N1-acetyltransferase (SSAT). J Biol Chem 2002;277:3647-57. (Pubitemid 34953238)
42. US Department of Agriculture. Agricultural Research Service. USDA National Nutrient Database for Standard Reference. Release 18, 2005 Nutrient Data Laboratory Home page. http://www.nal.usda.gov/fnic/foodcomp .
43. Zoumas-Morse C, Rock CL, Quintana EL, Neuhouser ML, Gerner EW, Meyskens FL Jr. Development of a polyamine database for assessing dietary intake. J Am Diet Assoc 2007;107:1024-7. (Pubitemid 46764596)
44. Deignan JL, Livesay JC, Shantz LM, Pegg AE, O'Brien WE, Iyer RK, et al. Polyamine homeostasis in arginase knockout mice. Am J Physiol Cell Physiol 2007;293:C1296-1301. (Pubitemid 47556745)
45. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
46. Fodde R. The APC gene in colorectal cancer. Eur J Cancer 2002;38:867-71. (Pubitemid 34442313)
47. Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J. Molecular biology of colorectal cancer. Curr Probl Cancer 1997;21:233-300.
48. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682-9. (Pubitemid 19213607)
49. Carson DA, Lois A. Cancer progression and p53. Lancet 1995;346:1009-11.
50. Chao A, Thun MJ, Connell CJ, McCullough ML, Jacobs EJ, Flanders WD, et al. Meat consumption and risk of colorectal cancer. JAMA 2005;293:172-82. (Pubitemid 40095868)
51. Murata M, Takayama K, Choi BC, Pak AW. A nested case-control study on alcohol drinking, tobacco smoking, and cancer. Cancer Detect Prev 1996;20:557-65. (Pubitemid 27017066)
52. Singh PN, Fraser GE. Dietary risk factors for colon cancer in a low-risk population. Am J Epidemiol 1998;148:761-74. (Pubitemid 28485286)
53. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993;75:631-9. (Pubitemid 23346362)
54. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990;247:322-4.
55. Bussey. Historical developments in familial adenomatous polypossis. In: Liss AR, editor. Familial Adenomatous Polyposis. New York, NY; 1990. p. 1-22
56. Erdman SH, Ignatenko NA, Powell MB, Blohm-Mangone KA, Holubec H, Guill n-Rodriguez JM, et al. APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse. Carcinogenesis 1999;20:1709-13. (Pubitemid 29410548)
57. Fultz KE, Gerner EW. APC-dependent regulation of ornithine decarboxylase in human colon tumor cells. Mol Carcinog 2002;34:10-8. (Pubitemid 34461652)
58. Ignatenko NA, Holubec H, Besselsen DG, Blohm-Mangone KA, Padilla-Torres JL, Nagle RB, et al. Role of c-Myc in intestinal tumorigenesis of the ApcMin/, mouse. Cancer Biol Ther 2006;5:1658-64.
59. Pietil M, Parkkinen JJ, Alhonen L, Jnne J. Relation of skin polyamines to the hairless phenotype in transgenic mice overexpressing spermidine/spermine N-acetyltransferase. J Invest Dermatol 2001;116:801-5. (Pubitemid 32467663)
60. Berger FG, Kramer DL, Porter CW. Polyamine metabolism and tumorigenesis in the Apc(Min/, ) mouse. Biochem Soc Trans 2007;35:336-9. (Pubitemid 46596503)
61. Yerushalmi HF, Besselsen DG, Ignatenko NA, Blohm-Mangone KA, Padilla-Torres JL, Stringer DE, et al. Role of polyamines in arginine-dependent colon carcinogenesis in Apc(Min) (/, ) mice. Mol Carcinog 2006;45:764-73. (Pubitemid 44484987)
62. Yerushalmi HF, Besselsen DG, Ignatenko NA, Blohm-Mangone KA, Padilla-Torres JL, Stringer DE, et al. The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis. Mol Carcinog 2006;45:93-105. (Pubitemid 43202582)
63. Zell JA, Ignatenko NA, Yerushalmi HF, Ziogas A, Besselsen DG, Gerner EW, et al. Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival. Int J Cancer 2007;120:459-68. (Pubitemid 44969014)
64. Lser C, Eisel A, Harms D, Flsch UR. Dietary polyamines are essential luminal growth factors for small intestinal and colonic mucosal growth and development. Gut 1999;44:12-6. (Pubitemid 29143274)
65. Ignatenko NA, Besselsen DG, Roy UK, Stringer DE, Blohm-Mangone KA, Padilla-Torres JL, et al. Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis. Nutr Cancer 2006;56:172-81. (Pubitemid 46417677)
66. Ignatenko NA, Besselsen DG, Stringer DE, Blohm-Mangone KA, Cui H, Gerner EW. Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis. Nutr Cancer 2008;60:30-5.
67. Roy UK, Rial NS, Kachel KL, Gerner EW. Activated K-RAS increases polyamine uptake in human colon cancer cells through modulation of caveolar endocytosis. Mol Carcinog 2008;47:538-53. (Pubitemid 351898584)
68. Closs EI, Simon A, V kony N, Rotmann A. Plasma membrane transporters for arginine. J Nutr 2004;134:2752S-29S; discussion 2765S-2767S.
69. Segawa H, Fukasawa Y, Miyamoto K, Takeda E, Endou H, Kanai Y. Identification and functional characterization of a Na,-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 1999;274:19745-51.
70. Torrents D, Est vez R, Pineda M, Fernndez E, Lloberas J, Shi YB, et al. Identification and characterization of a membrane protein (y, L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y, L. A candidate gene for lysinuric protein intolerance. J Biol Chem 1998;273:32437-45. (Pubitemid 28557616)
71. Uemura T, Stringer DE, Blohm-Mangone KA, Gerner EW. Polyamine transport is mediated by both endocytic and solute carrier transport mechanisms in the gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 2010;299:G517-522.
72. Boivin GP, Washington K, Yang K, Ward JM, Pretlow TP, Russell R, et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 2003;124:762-77. (Pubitemid 36268493)